rs386834161
Variant summary
Our verdict is Uncertain significance. Variant got 4 ACMG points: 4P and 0B. PM2PP5_Moderate
The NM_030943.4(AMN):c.1006+34_1007-31del variant causes a intron change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.0000615 in 1,512,914 control chromosomes in the GnomAD database, with no homozygous occurrence. Variant has been reported in ClinVar as Pathogenic (★).
Frequency
Genomes: 𝑓 0.00012 ( 0 hom., cov: 33)
Exomes 𝑓: 0.000054 ( 0 hom. )
Consequence
AMN
NM_030943.4 intron
NM_030943.4 intron
Scores
Not classified
Clinical Significance
Conservation
PhyloP100: 0.688
Genes affected
AMN (HGNC:14604): (amnion associated transmembrane protein) The protein encoded by this gene is a type I transmembrane protein. It is thought to modulate bone morphogenetic protein (BMP) receptor function by serving as an accessory or coreceptor, and thus facilitates or hinders BMP binding. It is known that the mouse AMN gene is expressed in the extraembryonic visceral endoderm layer during gastrulation, but it is found to be mutated in amnionless mouse. The encoded protein has sequence similarity to short gastrulation (Sog) and procollagen IIA proteins in Drosophila. [provided by RefSeq, Jul 2008]
Genome browser will be placed here
ACMG classification
Classification made for transcript
Verdict is Uncertain_significance. Variant got 4 ACMG points.
PM2
?
Very rare variant in population databases, with high coverage;
PP5
?
Variant 14-102930107-CCGCCCCGCCGCGCCT-C is Pathogenic according to our data. Variant chr14-102930107-CCGCCCCGCCGCGCCT-C is described in ClinVar as [Pathogenic]. Clinvar id is 56742.Status of the report is criteria_provided_single_submitter, 1 stars. Variant chr14-102930107-CCGCCCCGCCGCGCCT-C is described in Lovd as [Pathogenic].
Transcripts
RefSeq
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | MANE | UniProt |
---|---|---|---|---|---|---|---|
AMN | NM_030943.4 | c.1006+34_1007-31del | intron_variant | ENST00000299155.10 | |||
AMN | XM_011537202.4 | c.844+34_845-31del | intron_variant | ||||
AMN | XM_011537203.4 | c.844+34_845-31del | intron_variant |
Ensembl
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | TSL | MANE | Appris | UniProt |
---|---|---|---|---|---|---|---|---|---|
AMN | ENST00000299155.10 | c.1006+34_1007-31del | intron_variant | 1 | NM_030943.4 | P1 |
Frequencies
GnomAD3 genomes ? AF: 0.000125 AC: 19AN: 151992Hom.: 0 Cov.: 33
GnomAD3 genomes
?
AF:
AC:
19
AN:
151992
Hom.:
Cov.:
33
Gnomad AFR
AF:
Gnomad AMI
AF:
Gnomad AMR
AF:
Gnomad ASJ
AF:
Gnomad EAS
AF:
Gnomad SAS
AF:
Gnomad FIN
AF:
Gnomad MID
AF:
Gnomad NFE
AF:
Gnomad OTH
AF:
GnomAD3 exomes AF: 0.0000560 AC: 6AN: 107218Hom.: 0 AF XY: 0.0000337 AC XY: 2AN XY: 59396
GnomAD3 exomes
AF:
AC:
6
AN:
107218
Hom.:
AF XY:
AC XY:
2
AN XY:
59396
Gnomad AFR exome
AF:
Gnomad AMR exome
AF:
Gnomad ASJ exome
AF:
Gnomad EAS exome
AF:
Gnomad SAS exome
AF:
Gnomad FIN exome
AF:
Gnomad NFE exome
AF:
Gnomad OTH exome
AF:
GnomAD4 exome AF: 0.0000544 AC: 74AN: 1360814Hom.: 0 AF XY: 0.0000462 AC XY: 31AN XY: 670812
GnomAD4 exome
AF:
AC:
74
AN:
1360814
Hom.:
AF XY:
AC XY:
31
AN XY:
670812
Gnomad4 AFR exome
AF:
Gnomad4 AMR exome
AF:
Gnomad4 ASJ exome
AF:
Gnomad4 EAS exome
AF:
Gnomad4 SAS exome
AF:
Gnomad4 FIN exome
AF:
Gnomad4 NFE exome
AF:
Gnomad4 OTH exome
AF:
GnomAD4 genome ? AF: 0.000125 AC: 19AN: 152100Hom.: 0 Cov.: 33 AF XY: 0.000108 AC XY: 8AN XY: 74356
GnomAD4 genome
?
AF:
AC:
19
AN:
152100
Hom.:
Cov.:
33
AF XY:
AC XY:
8
AN XY:
74356
Gnomad4 AFR
AF:
Gnomad4 AMR
AF:
Gnomad4 ASJ
AF:
Gnomad4 EAS
AF:
Gnomad4 SAS
AF:
Gnomad4 FIN
AF:
Gnomad4 NFE
AF:
Gnomad4 OTH
AF:
Bravo
AF:
ClinVar
Significance: Pathogenic
Submissions summary: Pathogenic:2
Revision: criteria provided, single submitter
LINK: link
Submissions by phenotype
Imerslund-Grasbeck syndrome Pathogenic:2
Pathogenic, criteria provided, single submitter | clinical testing | Invitae | Jan 21, 2024 | This sequence change falls in intron 9 of the AMN gene. It does not directly change the encoded amino acid sequence of the AMN protein. RNA analysis indicates that this variant induces altered splicing and may result in an absent or disrupted protein product. This variant is present in population databases (rs386834161, gnomAD 0.02%). This variant has been observed in individuals with Imerslund-Gräsbeck syndrome (PMID: 22929189, 30691194). This variant is also known as c.1006+34_48del15bp. ClinVar contains an entry for this variant (Variation ID: 56742). Studies have shown that this variant results in skipping of exon 9 and introduces a premature termination codon (PMID: 22929189). The resulting mRNA is expected to undergo nonsense-mediated decay. For these reasons, this variant has been classified as Pathogenic. - |
Likely pathogenic, no assertion criteria provided | literature only | Juha Muilu Group; Institute for Molecular Medicine Finland (FIMM) | - | - - |
Computational scores
Source:
Name
Calibrated prediction
Score
Prediction
Splicing
Find out detailed SpliceAI scores and Pangolin per-transcript scores at